跳至主要内容
临床试验/NL-OMON49056
NL-OMON49056已完成4 期

rsodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy. - UPGRADE

Academisch Medisch Centrum0 个研究点目标入组 985 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
985

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Scheduled to undergo Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity
  • * An intact gallbladder

排除标准

  • * Symptomatic gallstone disease already present before RYGB
  • * Prior bariatric surgery
  • * Prior gallbladder surgery
  • * Ascertained or presumptive hypersensitivity to active or excipient ingredients of ursodeoxycholic acid.
  • * Inflammatory bowel disease and other conditions of the small intestine and liver which may interfere with enterohepatic circulation of bile salts (ileal resection and stoma, extra and intra-hepatic cholestasis, severe liver disease)
  • * Intake of investigational drug within the last 30 days before the screening

研究者

相似试验